AP
Apimeds Pharmaceuticals US, Inc (APUS)
AMEX·Healthcare·Biotechnology
$2.99
-2.13%
Mkt Cap $4.60M
No analyst coverage available
We don't have analyst ratings or price target data for Apimeds Pharmaceuticals US, Inc yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.